Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals (“Concert”) to acquire a portfolio of Concert’s CNS therapeutics and accompanying intellectual property. These deuterated compounds represent next-generation therapeutics with applications across…

thaipr.net

14 มี.ค. 65
1 2,415 2,416 2,417 2,418 2,419 3,330